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DObjectives: Few studies have been published in literature on outcomes of isolated tricuspid valve (TV) surgery
when performed as a reoperation. Hence, we analyzed our early and midterm results of TV surgery in this unique
group of patients.
Methods:We performed a retrospective analysis of 82 consecutive patients who underwent isolated TV surgery
as a reoperation at our institution between 1997 and 2010. Symptomatic TV regurgitation (84.2%), acute endo-
carditis (14.6%), and valve thrombosis after TV repair (1.2%) were the indications for surgery. A minimally
invasive access through a right anterolateral thoracotomy was the preferred approach in 60% of the patients.
Previous cardiac operations included mitral, aortic, and TV surgery in 60%, 29%, and 27% and coronary by-
pass surgery in 18%, usually performed as combined procedures. Elective surgery was performed in 67.1% of
the patients. Mean patient age was 64.1  11.9 years, 28% being male with an average logistic EuroSCORE of
16.4%  14.3%. Follow-up was 96% complete, with a mean duration of 2.6  2.4 years.
Results: Overall thirty-day mortality was 14.6%; for patients without and with endocarditis, it was 12.9% and
25%. Thirty-day mortality for patients undergoing elective surgery was 4.0%. Overall 2-year survival was
63.0%  5.5%. The 2-year freedom from TV-related reoperation was 93.5%  3.3%.
Conclusions: Postoperative results of isolated TV surgery as a reoperation are acceptable when performed elec-
tively but dismal in patients undergoing nonelective surgery. Thus, redo TV surgery, when indicated, should be
performed sooner rather than later. Minimally invasive surgery through a right lateral minithoracotomy is a safe
approach for patients with elective surgery. (J Thorac Cardiovasc Surg 2013;146:841-7)Isolated tricuspid valve (TV) surgery, especially as a reoper-
ation, is considered to be associated with high operative
risk. Although the operation may not be technically compli-
cated, the increased risk is usually due to the fact that pa-
tients are referred for surgery late in their disease process.
Such patients often have evidence of right heart failure
and associated complications. It is unknown whether poor
postoperative outcome is related to the severity of tricuspid
regurgitation (TR) itself or to the poor overall status of such
patients. In addition, patients with isolated TV disease and
previous cardiac surgery represent an even more challeng-
ing subgroup. Precise clinical outcomes for these challeng-
ing patients still need to be determined.
Only a handful of publications regarding outcome of pa-
tients with TV surgery as a reoperation have been published
so far, usually with small patient numbers.1-4 The results of
these studies are not uniform because of different patiente Department of Cardiac Surgery, Heart Center, University of Leipzig, Leip-
ermany.
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The Journal of Thoracic and Cacohorts and differences in valve disease. In these studies,
hospital mortality ranged from 0% to 37%.1-4
The optimal timing for surgery and the best surgical strat-
egy in these challenging patients remains unclear. The pur-
pose of this study was to review our single-center
experience of patients undergoing isolated TV surgery after
previous cardiac surgery in a relatively large number of
patients.
PATIENTS AND METHODS
Between March 1997 and December 2010, a total of 82 patients under-
went isolated TV repair or replacement as a reoperation at the Heart Center
Leipzig.
Indications for TV surgery were symptomatic TR in 69 (84.2%) pa-
tients; of these, the main TV disease was annulus dilatation in 49
(61.0%) patients, restriction of the leaflets in 12 (14.7%) patients, rolled
up and thickened leaflets in 3 (3.7%) patients, a dehiscence of the previ-
ously implanted ring in 2 (2.4%) patients, an atrophic TV in 1 (1.2%)
patient, and resection of the TV in the previous surgery owing to massive
endocarditis in 1 (1.2%) patient. In combination with the previously de-
scribed pathologic conditions were fenestrations of and adherences with
the leaflets owing to a pacemaker lead additionally responsible for TR in
8 (9.8%) patients.
Active endocarditis was the reason for TV surgery in 12 (14.6%) pa-
tients: intravenous drug abuse in 3 of these and vegetations on permanent
pacemaker leads with involvement of the TV in another 3 patients. In the
remaining 6 patients, the cause of endocarditis was unknown.
A pannus combined with thrombosis based on the previous implanted
tricuspid ring after TV repair resulting in TV stenosis was the reason for
repeat TV surgery in 1 (1.2%) patient.rdiovascular Surgery c Volume 146, Number 4 841
Abbreviations and Acronyms
CI ¼ confidence interval
CPB ¼ cardiopulmonary bypass
NYHA ¼ New York Heart Association
TR ¼ tricuspid regurgitation
TV ¼ tricuspid valve
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DPatients without (n ¼ 70, group 1) and with (n ¼ 12, group 2) pannus
were divided into 2 groups on the basis of the different pathologic condi-
tions, which could complicate the analysis.
In 55 (67.1%) patients, the operation was performed electively. In the
remaining patients, the operation was performed ‘‘nonelectively.’’ ‘‘Non-
elective’’ surgery was performed in the 12 patients with active endocarditis,
in 10 patients with preoperative global cardiac decompensation, in 4 pa-
tients with right heart decompensation, and in the patient with a pannus
combined with thrombosis based on the previously implanted tricuspid
ring after TV repair.
Preoperative, intraoperative, and postoperative parameters of all pa-
tients were prospectively entered into a patient data management system
and then retrospectively analyzed. In addition, further chart review and in-
formation from preoperative and predischarge echocardiographic reports
were collected and analyzed. TR was calculated by measurement of vena
contracta in a 4-chamber view.5
TV surgery was performed using standard techniques including bicaval
cannulation and mild hypothermic cardiopulmonary bypass (CPB). Pa-
tients were operated on via sternotomy (n ¼ 36, 43.9%) or minimally in-
vasive access (n ¼ 46, 56.1%). The minimally invasive technique via
a right anterolateral minithoracotomy has been described by our group
before.6
Surgery was performed either with aortic crossclamping and cardiople-
gic arrest (n ¼ 20; 24%) or without crossclamping and cardioplegia either
on the beating heart (n ¼ 57; 70%) or with a short period of ventricular
fibrillation (n ¼ 5; 6%).
TV repair or replacement was performed depending on the pathologic
condition of the valve and the surgeon’s choice. The surgical access, as
well as the decision to perform the operation with or without aortic cross-
clamping, was the surgeon’s choice as well.
Ethics approval was granted from the local ethics committee for this
investigation.
Follow-up
After discharge, all patients were contacted by mail and asked to answer
a specific questionnaire on an annual basis. Patients who did not respond
were contacted by telephone. If no further information about the patients
was available, family physicians were contacted directly. Follow-up was
97% complete with a mean follow-up time of 2.6  2.4 years (range, 1
day-11.3 years).
With patient agreement, we additionally contacted the patient’s cardiol-
ogist to obtain the most recently performed postoperative echocardio-
graphic report, which was available in 45% of the surviving patients at
a mean follow-up time of 3.2  2.2 years (range, 35 days-9.4 years).
Statistical Evaluation
Results are displayed in the standard format with continuous variables
expressed as mean standard deviation and categorical data as proportions
throughout the manuscript. Risk analysis was done with binary logistic
regression analysis. Cumulative survival, as well as the freedom from
valve-related reoperation, was calculated by Kaplan-Meier methods. Dif-
ferences in follow-up were calculated with 95% confidence limits and
compared by log–rank (Mantel-Cox) test.842 The Journal of Thoracic and Cardiovascular SurgAll statistical analyses were performed using SPSS statistical package
17.0 (SPSS Inc, Birmingham, Ala).RESULTS
Overall, 82 patients underwent isolated TV surgery as
a reoperation during the study period. Mean age of all pa-
tients was 64.1  11.9 years (range, 22-83 years). In the
whole cohort were 23 male patients (28%). Average New
York Heart Association (NYHA) class was 2.6  0.7.
Left ventricular function was normal in the majority of pa-
tients and atrial fibrillation was present in 29 (35.4%) pa-
tients. Table 1 shows the demographic data of all patients
undergoing isolated TVoperation, as well as those of groups
1 and 2 (ie, patients without and with endocarditis).
There were significantly more patients with atrial fibrilla-
tion and arterial hypertension in group 1 than in group 2.
In a total of 55 (67.1%) patients, surgery was performed
electively.
In 20 (24.4%) patients, a previous TVoperation was per-
formed; 16 of these operations were TV repair. Figure 1 dis-
plays the previous cardiac procedures, broken down into the
2 patient groups. Previous left-sided surgery was performed
in 55 (67.1%) patients.
Preoperative echocardiography showed severe TR 3þ to
4þ in 76 (92%) patients, in 68 patients of group 1 and in 8
patients of group 2. TR 2þwas present in 3 (4%) patients,
in 1 of group 1 and 2 of group 2. Mild or even no TR at
the time of surgery was present in 3 (4%) patients: 1 patient
of group 1 had a thrombus with secondary tricuspid stenosis
after previous TV repair, 1 patient (group 2) had endocarditis
of a mechanical tricuspid prostheses, and 1 patient (group 2)
had a vegetation of an implantable cardioverter defibrillator
lead with involvement of the TV without significant TR.
There were significant differences in the distribution of pre-
operative TR in both groups (P<.01).
Intraoperative and perioperative data are shown inTable 2.
Operation, crossclamp, and CPB times were 174  66 min-
utes, 57  28 minutes, and 101  49 minutes and were
comparable in patients with and without endocarditis. Intra-
operative procedures are shown in Figure 2.
Minimally invasive surgery through a right lateral mini-
thoracotomy with femoral cannulation for CPB was used
in 42 (60.0%) of the patients in group 1 and in 4 (33.3%)
of the patients in group 2. TV surgery in the remaining pa-
tients was performed via median sternotomy.
Therewere significantly shorter operation and crossclamp
times for patients undergoing minimally invasive surgery
compared with patients with sternotomy (operation time,
168 56minutes vs 183 79minutes; P¼ .03; crossclamp
time, 27 18minutes vs 48 38minutes;P¼ .02) and com-
parable CPB times (103  47 minutes vs 94  54 minutes;
P ¼ .5). Operation, crossclamp, and CPB times were 171
 66 minutes, 57  28 minutes, and 101  49 minutes and
were comparable in patients with and without endocarditis.ery c October 2013
TABLE 1. Demographic patient data
All patients (n ¼ 82) No endocarditis (n ¼ 70) Endocarditis (n ¼ 12) P value
Age (y) 64.12  11.9 65.2  10.9 57.9  16.0 .15
Male 23 (28.0%) 18 (25.7%) 5 (41.7%) .3
Atrial fibrillation 29 (35.4%) 27 (38.6%) 2 (16.7%) .01
Arterial hypertension 50 (61.0%) 45 (64.3%) 5 (41.7%) .03
Diabetes mellitus 16 (19.5%) 14 (14.8%) 2 (16.7%) .6
Body mass index 25.2  4.2 24.8  3.6 28.0  6.1 .1
Preop NYHA 2.6  0.7 2.6  0.6 2.5  1.2 .9
logEuroSCORE 16.4%  14.3% 15.1%  12.7% 24.2%  20.7% .17
LVEF 50.7%  23.5% 56.7%  13.7% 61.2%  10.4% .3
Pulmonary artery pressure 43.8  21.8 43.5  21.5 46.5  29.1 .7
No. of thrombocytes 202.0  90.9 205.9  94.1 180.6  70.0 .4
Permanent Pacemaker/AICD 34 (41.4%) 31 (44.3%) 3 (25.0%) .4
TV reoperation 20 (24.4%) 16 (122.9%) 4 (33.3%) .09
Previous left-sided surgery 58 (72.5%) 52 (76.5%) 6 (50.0%) .06
Preop NYHA, Preoperative New York Heart Association; logEuroSCORE, logistic EuroSCORE predicted risk of operative mortality; LVEF, left ventricular ejection fraction;
AICD, automatic implantable cardioverter defibrillator; TV, tricuspid valve.
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DThe tricuspid procedurewas performedwith a crossclamp
and cardioplegic arrest in 20 (24%) patients. In the remain-
ing 62 patients, surgery was done with the heart beating
(n¼ 57, 70%) or during ventricular fibrillation (n¼ 5, 6%).
A mechanical (n ¼ 7) or biological (n ¼ 13) TV replace-
ment was performed in 20 (24%) patients. These operations
were performed owing to excessive retraction of the leaflets
in 11 patients, thickened and rolled up leaflets in 3 patients,
active endocarditis in 3 patients, a previously resected TV
because of endocarditis in 1 patient, atrophic leaflets in 1FIGURE 1. Surgical procedures performed in patients with and without
endocarditis. MVR, Mitral valve repair/replacement; TVR, tricuspid valve
repair/replacement; CABG, coronary artery bypass grafting; AVR, aortic
valve repair/replacement.
The Journal of Thoracic and Capatient, and excessive pannus and thrombus after TV repair
in 1 patient.
In this patient group were included 8 of the 16 patients
with previous TV repair.
TV repair was performed in the remaining 62 (76%) pa-
tients. Of these, 8 of 16 patients had a previous TV repair.
Residual TR 3þwas present in 5 (8.0%) patients and pre-
discharge TR 2þin 9 (12.3%) patients, in all cases after TV
repair. No patient with preoperative endocarditis had resid-
ual moderate or more TR.
TR 2þ/3þwas caused by central regurgitation in all 14 pa-
tients. A preoperatively inserted permanent pacemaker lead
was suspected to be the cause of the central TR in 3 of the 14
patients.
Reoperation owing to bleeding complications was neces-
sary in a total of 12 (14.6%) patients, 7 (8.5%) with post-
operative active bleeding and 5 (6.1%) with relevant
pericardial or pleural hematoma that developed some days
after the operation.
Postoperative low cardiac output syndrome occurred in
12 (14.6%) patients. Four (4.9%) were treated with extrac-
orporal membrane oxygenation and 3 (3.7%) with an intra-
aortic balloon pump.
Postoperative implantation of a permanent pacemaker
was necessary in 7 (8.5%) patients. We did not observe
a significant difference in pacemaker requirements for pa-
tients who underwent TV repair versus TV replacement
(P ¼ .2).
New postoperative permanent neurologic deficits were
detected in 4 (4.9%) patients, during postoperative extrac-
orporal membrane oxygenation in 2 of them (1 patient
with cerebral edema and 1 patient with fulminant cerebral
bleeding). The 2 remaining patients had previously im-
planted mechanical mitral and mechanical mitral and aortic
valve replacement, respectively, and on computedrdiovascular Surgery c Volume 146, Number 4 843
TABLE 2. Perioperative patient characteristics
All patients (n ¼ 82) No endocarditis (n ¼ 70) Endocarditis (n ¼ 12) P value
Operation time (min) 174.3  66.3 171.0  60.1 188.8  97.3 .4
Patients operated on with crossclamp 20 (24.4%) 15 (21.4%) 5 (41.7%) .3
Crossclamp time (min) 57.0  28.3 52.3  25.1 70.0  36.4 .3
CPB time (min) 100.9  48.7 101.9  45.8 95.3  64.8 .4
Minimally invasive access 46 (56.1%) 42 (60.0%) 4 (33.3%) .09
Preop TR 3.2  0.7 3.4  0.6 2.5  1.1 .02
Postop TR 0.9  0.9 0.9  0.9 0.5  0.5 .03
Postop LVEF 53.8  13.1 54.0  12.7 52.4  16.6 .7
Data are mean  standard deviation. CPB, Cardiopulmonary bypass; preop/postop TR, preoperative/postoperative tricuspid regurgitation grade; postop LVEF, postoperative left
ventricular ejection fraction.
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verified, resulting in a hemiparesis of the left arm and epi-
leptic seizures, respectively.
Overall 30-day mortality was 14.6% with 9 (12.9%)
deaths occurring in group 1 and 3 (25.0%) deaths in group
2 (P¼ .3). Overall early mortality after elective surgery was
4.0% with 2 deaths; after minimally invasive surgery, early
mortality was 0%. Early mortality after nonelective surgery
was 31.2% with 10 deaths (P ¼ .01).
We performed a binary logistic regression analysis to
determine the independent risk factors for early mortality
with the covariates gender, age, preoperative left ventricu-
lar ejection fraction, preoperative NYHA, body mass
index, logistic EuroSCORE, priority for surgery, pulmo-
nary hypertension, method for TV surgery (TV surgery
performed with crossclamping, beating heart, or ventricu-
lar fibrillation), endocarditis, previous left-sided surgery,
and approach for surgery. Only elective surgery (oddsFIGURE 2. Intraoperative surgical procedures in patients with and with-
out endocarditis.
844 The Journal of Thoracic and Cardiovascular Surgratio, 9.8) was revealed as a protective factor for early
mortality.
Midterm survival of all patients at 2 years was 63.0% 
5.5% (95% confidence interval [CI], 44-73). Two-year
survival was 66.0%  5.8% (95% CI, 46-99) in group 1
patients versus 45.0.7%  15.6% (95% CI, 16-49) in
group 2 (log–rank P ¼ .25). There was a significant differ-
ence (P< .001) in patients undergoing elective and non-
elective surgery with 2-year survivals of 78.5%  6.1%
(95% CI, 55-94) and 38.4%  8.8% (95% CI, 28-42),
as shown in Figure 3. There was no significant difference
between the long-term survival of patients with
persistent TR 2/3þ after TR repair in regard to patients
with TR 0/1þ (P ¼ .3).
Midterm freedom from TV-related reoperation is de-
picted in Figure 4. After 2 years, freedom from
TV-related reoperation was 93.5%  3.3% (95% CI,
98-129) for all patients, 96.8%  2.2% (95% CI, 25-55)
for patients without, and 67.5%  20.7% (95% CI,
106-134) for patients with endocarditis, respectively
(P¼ .03). TV reoperation had to be performed in 7 patients
between 21 days and 3 years postoperatively because of the
following reasons: severe, symptomatic central TR in 2 pa-
tients, ring dehiscence with severe TR in another patient,
thrombosis of a previous TV repair in 1 patient, recurrent
endocarditis after TV replacement in the presence of
drug abuse in 2 patients, and endocarditis in 1 patient after
TV replacement with acute myeloid leukemia in his
history.
Postoperative echocardiographic data with a mean
follow-up time of 3.2  2.2 years were available in 25
of the surviving patients. Worsening of the predischarge
level of TR was observed 2 patients who underwent TV
repair and reoperation and in 2 of 6 patients who under-
went biological TV replacement. The latter patients were
36 and 38 years old at the time of surgery and had no
TR on the predischarge echocardiogram, but 4 years later
had TR 2þ to 3þ.
Postoperative NYHA classification in follow-up was
on average 2.4  0.9. During follow-up, 2 bleeding
complications (0.9%/patient-year) were observed withery c October 2013
FIGURE 3. Postoperative survival for patients with elective and nonelec-
tive surgery.
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Dhemodynamically relevant nasal bleeding under anticoagu-
lation, both in patients with TV repair and mechanical mi-
tral and mechanical mitral and aortic prostheses,
respectively. During follow-up, new permanent pacemakers
were implanted in 2 patients and 1 intravenous pacemaker
lead was changed into a coronary sinus lead (1.4%/pa-
tient-year).
We failed to find any difference between patients who re-
ceived tricuspid repair or replacement with regard to 30-dayFIGURE 4. Postoperative freedom from tricuspid valve–related reopera-
tion for patients with and without endocarditis. TV, Tricuspid valve.
The Journal of Thoracic and Camortality, midterm survival, and freedom from TV-related
reoperation.
DISCUSSION
We have shown that patients undergoing isolated TV
surgery as a reoperation have a good early clinical outcome
if surgery is performed as an elective procedure. Clinical
outcomes are markedly worse if surgery is performed
on an urgent basis owing to endocarditis or cardiac
decompensation.
Our results are in agreement with those of the literature.
TV reoperations owing to rheumatic TR in combination
with other cardiac procedures show excellent early postop-
erative results with very low hospital mortality7,8 if
performed as an elective procedure. On the other hand,
Bernal and associates3 showed a hospital mortality of
35.1% in patients who underwent TV reoperations after
previous TV repair. This high mortality rate may be related
to the fact that the authors did not differentiate between pa-
tients requiring elective or emergency surgery. Although the
study is not completely comparable with our data because
Bernal and colleagues focused on patients with reoperation
of the TV itself and we focused on patients with previous
cardiac surgery and indication for isolated TV surgery, Ber-
nal’s data may give some insights into this high-risk group
of patients undergoing reoperative TV surgery.
In our entire patient group, we could demonstrate
a 30-day mortality rate of 14.6%, reflecting the increased
risk associated with reoperative TV surgery. However, we
observed a large difference in mortality between patients
having elective and nonelective procedures (4.0% vs
35.7%, respectively). As Figure 3 demonstrates, survival
after reoperative TV repair is mainly related to early postop-
erative mortality, inasmuch as the curve of the nonelective
group drops dramatically in the early postoperative course.
The risk of early mortality for patients with elective surgery
as compared with patients with nonelective surgery was sig-
nificantly higher with an odds ratio of 10. Two-year survival
for patients with nonelective surgery was 38.4%  8.8%
(95% CI, 28-42). In comparison, the 2-year survival of
patients with conservatively treated severe TR is
approximately 40%, as described by Nath, Foster, and
Heidenreich.9
Another interesting point is the early mortality of 0% for
patients with elective minimally invasive surgery in our co-
hort. This observation is probably related to selection bias,
inasmuch as 70% of the patients with elective and only
39% of the patients with nonelective surgery were treated
in a minimally invasive fashion. That said, minimally inva-
sive surgery could be advantageous in certain situations. To
evaluate the position of the heart and exclude excessive ad-
hesions between the right chest and lung, we routinely per-
form a computed tomographic scan preoperatively. If
minimally invasive surgery is possible owing to expectedrdiovascular Surgery c Volume 146, Number 4 845
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and the right femoral and internal jugular veins. We intro-
duce a Fogarty catheter through the femoral and jugular
veins to block the inferior and superior venae cavae for re-
operative TV procedures, which avoids the need for dissec-
tion and clamping or snaring of the venae cavae. To avoid
dissection of the aorta, we usually perform the procedure
on a beating heart or in ventricular fibrillation when a mini-
mally invasive approach is used. Fukuda and associates10
use a similar cannulation technique for patients with TV re-
operation performed through a median sternotomy, block-
ing the inferior vena cava with a Foley catheter. These
authors speculate that this technique is an advantage in
these patients, associated with excellent drainage with low
venous pressure. In addition, this technique avoids cannula-
tion of a dilated azygos or hepatic vein and minimizes dis-
section of the right atrium and ventricle, which again
minimizes postoperative bleeding. We are convinced that
prevention of dissection of the right ventricle, which is pos-
sible in minimally invasive surgery, is additionally protec-
tive against dilatation of the right ventricle after surgery
that would result in poor right heart function.
TV repair was performed in nearly 75% of our patients.
However, 17% of all repaired valves continued to have re-
sidual TR 2þto 3þat predischarge echocardiography. There
was no worsening of TR in echocardiographic follow-up in
those patients who had available data.
However, the intraoperative decision for TV repair or re-
placement in these patients is challenging. Preoperative
poor right ventricular function may result in further ventric-
ular deterioration after TV replacement when the ventricle is
challenged with the whole blood volume. However, wewere
unable to display a difference in outcomes between patients
who underwent TV repair or replacement in our cohort, al-
though only 20 patients underwent TV replacement surgery.
Kunadian and associates11 reviewed studies regarding
long-term results after mechanical and biological TV re-
placement and found no major differences regarding sur-
vival or reoperation rates. Our policy is to use
bioprosthetic valves for TV replacement in nearly all pa-
tients, regardless of patient age or presence of a previously
implanted mechanical prosthesis in the aortic and/or mitral
position. We prefer biological TV replacement to avoid ex-
cessive anticoagulation, which is necessary in patients with
a mechanical TV replacement owing to the low pressure in
the right atrium and ventricle. On the other hand, we were
surprised to find 2 young patients (36 and 38 years old at
time of surgery) with moderate and severe TR 4 years after
biological TV replacement, despite normal predischarge
echocardiographic findings.
We found 3 patients with a permanent pacemaker and
predischarge central TR 2þ to 3þafter TV repair, in whom
the pacemaker lead was described to interfere with the
movement of the TVon echocardiography. In none of these846 The Journal of Thoracic and Cardiovascular Surgpatients was interference of the permanent pacemaker lead
with the coaptation of the TV observed intraoperatively.
McCarthy and coworkers4 described transtricuspid perma-
nent pacemaker leads as a risk factor for postoperative fail-
ure of TV repair and concluded that all permanent
pacemaker leads should be removed intraoperatively and
replaced epicardially. In our own experience,12 we prefer
to replace permanent pacemaker leads during TV repair
only if they seem to interfere with TV leaflet mobility
when tested on the beating heart intraoperatively.
We routinely place an epimyocardial pacemaker lead at
the time of surgery in patients undergoing TV replacement,
even in those undergoing minimally invasive surgery. In TV
reoperations, minimally invasive epimyocardial implanta-
tion is very difficult and results in poor sensing and pacing
because of adhesions and fibrosis. We therefore place a cor-
onary sinus lead in such patients and tunnel this lead
through the atrial wall.
If a new permanent pacemaker is required in a patient
with a previous TV replacement, we prefer to implant the
pacemaker lead into the coronary sinus.13 Another option
in patients with a bioprosthesis is the transvenous placement
of a new lead directly through the prosthesis,14 although this
is not routinely recommended. This can be done either intra-
operatively or some days after the operation.
Another possibility for TV replacement surgery in the case
of a pre-existing permanent pacemaker lead is to place it be-
tween the native annulus and the sewing ring of the TV, but
this technique may induce a small paravalvular leak and may
lead to a difficult lead removal in the future, if required.12,15
The current study has some limitations, not only because
of its retrospective nature. Our patient population is small
because of the rarity of patients requiring isolated reopera-
tive TV surgery. The patient group is also very heteroge-
neous, which complicates comparisons of subgroups. The
status ‘‘elective’’ or ‘‘urgent’’ indication for surgery was
prospectively given by the surgeon at the point of surgery
on the basis of the patient’s clinical aspect and is partially
subjective. However, these limitations apply to all retro-
spectively isolated TV surgery series. Follow-up time is
only 2.6 years on average, and we were not able to present
a complete echocardiographic follow-up after discharge.
Such information would have been particularly interesting
for patients with TV repair. Despite these limitations, to
the best of our knowledge the current series is one of the
largest of isolated reoperative TV surgery to date.
We conclude that TV surgery as a reoperation can be
done with good clinical outcomes if performed electively.
Minimally invasive surgery through a right lateral minithor-
acotomy is a safe approach for these patients.References
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